Last reviewed · How we verify
MTC896 Gel
At a glance
| Generic name | MTC896 Gel |
|---|---|
| Sponsor | Mimetica Pty Limited |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris (PHASE2)
- Pharmacokinetic Study of MTC896 Gel in Subjects With Acne (PHASE1, PHASE2)
- Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MTC896 Gel CI brief — competitive landscape report
- MTC896 Gel updates RSS · CI watch RSS
- Mimetica Pty Limited portfolio CI